UMPS
Uridine 5'-monophosphate synthase
Also known as: UMPS_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P11172
- Gene
- UMPS
- Ensembl
- ENSG00000114491
- Chromosome
- 3
- Canonical length
- 480 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a uridine 5'-monophosphate synthase. The encoded protein is a bifunctional enzyme that catalyzes the final two steps of the de novo pyrimidine biosynthetic pathway. The first reaction is carried out by the N-terminal enzyme orotate phosphoribosyltransferase which converts orotic acid to orotidine-5'-monophosphate. The terminal reaction is carried out by the C-terminal enzyme OMP decarboxylase which converts orotidine-5'-monophosphate to uridine monophosphate. Defects in this gene are the cause of hereditary orotic aciduria. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
Canonical amino-acid sequenceUniProt
480 residues, UniProt reviewed canonical sequence.
>P11172|UMPS
1 MAVARAALGP LVTGLYDVQA FKFGDFVLKS GLSSPIYIDL RGIVSRPRLL SQVADILFQT
61 AQNAGISFDT VCGVPYTALP LATVICSTNQ IPMLIRRKET KDYGTKRLVE GTINPGETCL
121 IIEDVVTSGS SVLETVEVLQ KEGLKVTDAI VLLDREQGGK DKLQAHGIRL HSVCTLSKML
181 EILEQQKKVD AETVGRVKRF IQENVFVAAN HNGSPLSIKE APKELSFGAR AELPRIHPVA
241 SKLLRLMQKK ETNLCLSADV SLARELLQLA DALGPSICML KTHVDILNDF TLDVMKELIT
301 LAKCHEFLIF EDRKFADIGN TVKKQYEGGI FKIASWADLV NAHVVPGSGV VKGLQEVGLP
361 LHRGCLLIAE MSSTGSLATG DYTRAAVRMA EEHSEFVVGF ISGSRVSMKP EFLHLTPGVQ
421 LEAGGDNLGQ QYNSPQEVIG KRGSDIIIVG RGIISAADRL EAAEMYRKAA WEAYLSRLGVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against UMPS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 2.9 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 2.9 nTPM
- liver: 2.5 nTPM
- spleen: 2.4 nTPM
- cerebellum: 2.3 nTPM
- colon: 2.2 nTPM
- pancreas: 2.1 nTPM
Single-cell type
- syncytiotrophoblasts: 140 nCPM
- cytotrophoblasts: 86 nCPM
- migrating cytotrophoblasts: 73 nCPM
- erythrocyte progenitors: 60 nCPM
- esophageal basal cells: 55 nCPM
- gastric progenitor cells: 54 nCPM
Immune cell
- naive B-cell: 25 nTPM
- memory B-cell: 17 nTPM
- myeloid DC: 15 nTPM
- gdT-cell: 14 nTPM
- naive CD4 T-cell: 14 nTPM
- NK-cell: 13 nTPM
Brain region
- white matter: 7.8 nTPM
- medulla oblongata: 7.3 nTPM
- cerebellum: 7 nTPM
- cerebral cortex: 6.5 nTPM
- hippocampal formation: 6.4 nTPM
- amygdala: 6.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about UMPS.
Disease | AllUniProt
Conditions UMPS is implicated in, by any mechanism.
- Orotic aciduria 1 (ORAC1) MIM:258900
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 294 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Oroticaciduria
- Cardiomyopathy
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.14
- DepMap mean gene effect
- -0.39
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 11% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 'de novo' pyrimidine nucleobase biosynthetic process
- 'de novo' UMP biosynthetic process
- pyrimidine nucleobase biosynthetic process
- UDP biosynthetic process
- UMP biosynthetic process
Molecular functions
- identical protein binding
- orotate phosphoribosyltransferase activity
- orotidine-5'-phosphate decarboxylase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Phosphoribosyltransferase domain
- Ribulose-phosphate binding barrel
- Aldolase-type TIM barrel
- Phosphoribosyltransferase-like
- Phosphoribosyl transferase domain
- Orotidine 5'-phosphate decarboxylase domain
- Orotate phosphoribosyl transferase domain
- Orotidine 5'-phosphate decarboxylase
- Orotidine 5'-phosphate decarboxylase, active site
- Orotate phosphoribosyltransferase
- Orotidine 5'-phosphate decarboxylase / HUMPS family
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UMPS as an antibody target. Whether an autoantibody or antibody against UMPS could matter depends on whether native UMPS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UMPS is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label UMPS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...